NIRAMAI Health Analytix, an innovative health tech startup based out of India, dedicated to early breast cancer detection, proudly announces its collaboration with Action Pink, a renowned NGO based in Germany. This partnership marks a significant milestone in the global fight against breast cancer.
About NIRAMAI Health Analytix
NIRAMAI, established in 2016, has pioneered a novel radiation-free screening test that is revolutionizing breast cancer screening with its innovative Artificial Intelligence-based technique called Thermalytix®. The mission of NIRAMAI is to enable non-invasive technology enabled solutions for early detection of cancer. Thermalytix is a portable breast cancer detection device which ensures patient privacy and also offers a painless experience with accurate results.
About Action Pink
Aktion Pink, established in 1999, has been instrumental in raising awareness about breast cancer and advocating for early stage breast cancer detection strategies. Led by CEO Corinna Saric, Action Pink empowers individuals with knowledge and resources to combat breast cancer effectively.
Uniting Technology and Advocacy for Global Impact
The collaboration between NIRAMAI Health Analytix and Action Pink significantly unites efforts to combat breast cancer globally. By combining innovative technology with advocacy and awareness initiatives, the partnership aims to enhance early detection rates and improve outcomes for individuals affected by breast cancer.
Insights from the CEOs
We are thrilled to join forces with Action Pink with our shared mission to create a life-saving impact through awareness creation and early detection of cancer. ” says Dr. Geetha Manjunath, CEO of NIRAMAI Health Analytix.
“We believe that by working together, we can make a meaningful impact in the fight against breast cancer,” adds Corinna Saric, CEO of Action Pink.
